Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab

The same mechanisms that mediate antitumor immunity from checkpoint inhibitors (CPIs) can also lead to unintended targeting of normal tissues, characterized as immune-related adverse events (irAEs). Those with pre-existing autoimmune disease are believed to be particularly vulnerable for exacerbatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jamie S, Wang, Daniel Y, Mamlouk, Omar, Glass, William F, Abdelrahim, Maen, Yee, Cassian, Abudayyeh, Ala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537330/
https://www.ncbi.nlm.nih.gov/pubmed/33020246
http://dx.doi.org/10.1136/jitc-2020-001287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537330/
https://www.ncbi.nlm.nih.gov/pubmed/33020246
http://dx.doi.org/10.1136/jitc-2020-001287

Ejemplares similares